Public consultation on items to be considered by the PBAC (July 2024)

Overview

Consultation has opened for the July 2024 Pharmaceutical Benefits Advisory Committee (PBAC) agenda.

The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. 

The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant.

How to provide input

• Input can be submitted via the online survey.  A copy of the questions asked in the survey and additional guidance can be downloaded below under ‘Related’ to assist your preparation.
• There is the option to upload a file with your submission. The preferred file types are PDF or Microsoft Word, however other file types will be accepted, provided they are no larger than 25mb. If your file is too large, or you wish to upload more than one file, please contact commentsPBAC@health.gov.au
• You can save and come back at any time to your response before the consultation close date.
• Once you have submitted, a copy of your submission will be emailed to the contact email address provided.

Providing input on more than one medicine? You will need to complete a separate survey for each medicine. Alternatively, email your input to commentsPBAC@health.gov.au

In the last question we welcome your comments and suggestions on ways to improve the survey and this process. All responses are considered after each round of consultation, and improvements are then made to the survey and its guidance where appropriate.

Please note in week 8 of the PBAC cycle, the PBAC agenda will be updated to include early pathways resubmissions and items for review.